Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 78 days ( 0 % )
Last Price $0.0920 0 %
High/ Low $0.0920 - $0.0920 0%
Chg 7 Days N/A $0.0920 $0.0920
Chg 30 Days N/A $0.0920 $0.0920
Chg 12 mos -80.80 % $0.479 $0.0920
Trend - 3 mos N/A Width: 0.00000000 %
Trend - 12 mos -80.63 % Width: 159.54 %
Pred. range - 3 mos $0.0920 - $0.0920 0 % - 0 %
Pred. range - 12 mos N/A - $0.0228 -100.00 % - -75.18 %
Short MA avg 3 mos Sell 0000-00-00 - N/A days
Long MA avg 3 mos Buy 2022-11-17 - 48 days
Short/Long MA avg 3 mos Buy 2022-11-17 - 48 days
Short MA avg 12 mos Buy 2022-10-17 - 71 days
Long MA avg 12 mos Sell 0000-00-00 - N/A days
Short/Long MA avg 12 mos Sell 0000-00-00 - N/A days
Pivot Short Sell 2023-01-26 - 2 days
Bollinger Sell 0000-00-00 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About CytRx Corporation

CytRx Corporation, a biopharmaceutical research and development company, focuses on oncology and rare diseases. It engages in the discovery, research, and clinical development of novel anti-cancer drug candidates that employ novel linker technologies to enhance the accumulation and release of cytotoxic anti-cancer agents at the tumor. The company's lead candidates include linker activated drug release (LADR) -7, LADR-8, LADR-9, and LADR-10; and A... CYTR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT